Design, synthesis, and activity of 2,3-diphosphoglycerate analogs as allosteric modulators of hemoglobin O2affinity
Source abstract
Abstract
Four phosphonate derivates of 2,3-diphosphoglycerate (2,3-DPG), in which the phosphate group is replaced by a methylene or difluoromethylene, were successfully synthesized for use as allosteric modulators of hemoglobin (Hb) O2 affinity. The syntheses were accomplished in four steps and the reagents were converted to their potassium salts to allow for effective binding with Hb in aqueous media. O2 equilibrium measurements of the chemically modified Hbs exhibited P50 values in the range 8.9-12.8 with Hill coefficients in the range of 1.5-2.4.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Organophosphorus compounds synthesis · Hemoglobin structure and function · Hemoglobinopathies and Related Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Astrup P · Academic Press: New York · 1971
2. Bakker JC · Biomater Artif Cells Immobilization Biotechnol · 1992 · 20 · 23310.3109/10731199209119638 ↗
3. Berkowitz DB · J Org Chem · 1995 · 60 · 704710.1021/jo00126a073 ↗
4. Blackburn GM · J Chem Soc Chem Commun · 1981 · 11 · 51110.1039/C39810000511 ↗
5. Blackburn GM · Chem Ind (London) · 1981 · 5
6. Burke TR · Org Chem · 1993 · 58 · 133610.1021/jo00058a009 ↗
7. Caplan NA · Bioorg Med Chem Lett · 1998 · 8 · 51510.1016/S0960-894X(98)00059-6 ↗
8. Chambers RD · Chem Commun · 1990 · 15 · 105310.1039/c39900001053 ↗
9. Engel R · Chem Rev · 1977 · 77 · 34910.1021/cr60307a003 ↗
10. Gould SA · Artificial blood: current status of hemoglobin solutions. Crit Care Clin · 1992 · 8 · 293
11. Horton H · Principles of Biochemistry. New Jersey: Neil Patterson · 1993
12. Kamber M · Can J Chem · 1985 · 63 · 82510.1139/v85-136 ↗
13. Kennedy J · Patent Brit 778,077 · 1957 · 51 · 17980b
14. Macdonald VW · Oxygen Delivery and myocardial function in rabbit hearts perfused with cell-free hemoglobin. J Appl Physiol · 1992 · 72 · 476
15. Moonen K · Chem Rev · 2004 · 104 · 617710.1021/cr030451c ↗
16. Palacios F · Chem Rev · 2005 · 105 · 89910.1021/cr040672y ↗
17. Palmer AF · Tangential flow filtration of hemoglobin. Biotechnol Prog · 2009 · 25 · 189
18. Schreiber GB · The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med · 1996 · 334 · 1685
19. Spahn DR · Current status of artificial oxygen carriers. Adv Drug Deliv Rev · 2000 · 40 · 14310.1016/S0169-409X(99)00046-0 ↗
20. Stremler KE · Am Chem Soc · 1987 · 109 · 554210.1021/ja00252a050 ↗
21. Thatcher GRJ · J Org Chem · 1993 · 58 · 227210.1021/jo00060a050 ↗
22. Tozer MJ · Tetrahedron · 1996 · 52 · 861910.1016/0040-4020(96)00311-0 ↗
23. Tsai A · Am J Physiol Heart Cric Physiol · 2003 · 285 · 141110.1152/ajpheart.00307.2003 ↗
24. Waschbüsch R · Chem Rev · 1997 · 97 · 340110.1021/cr9700078 ↗
25. Wettstein R · Crit Care Med · 2003 · 31 · 182410.1097/01.CCM.0000069340.16319.F2 ↗
26. Wiemer DF · Tetrahedron · 1997 · 53 · 1660910.1016/S0040-4020(97)10305-2 ↗
27. Winslow RM · Blood substitutes, a moving target. Nat Med · 1995 · 1 · 1212
28. Winslow RM · J Intern Med · 2003 · 253 · 50810.1046/j.1365-2796.2003.01150.x ↗